| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | SAREPTA THERAPEUTICS INC | 28,799 | 790,000 | 0.09% | ||
| 52 | ALNYLAM PHARMACEUTICALS INC | 19,899 | 745,000 | 0.08% | ||
| 53 | TRILLIUM THERAPEUTICS INC | 100,000 | 565,000 | 0.06% | ||
| 54 | PROFOUND MEDICAL CORP | 495,900 | 414,000 | 0.05% | ||
| 55 | PRONAI THERAPEUTICS | 201,660 | 367,000 | 0.04% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-17-008034, filed 2017.02.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
